Michael Frazier, DPM
Podiatrist · Shenandoah, TXNPI 1881958940
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $13,325 of the $19,166 with a category attached, or 69.5%. Stryker accounts for 88.8% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $9,276 and has fallen 97.2% since, to $257 in 2025. Among podiatrist clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 57 payments — averaging $336.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$17K
- Bone Support Inc.$2K
- Sanara Medtech Inc.$43
- Amgen$38
- Smith+Nephew$31
- Paratek Pharmaceuticals, Inc.$30
- plus $129 from 6 others
What the payments were for
- Consulting fees$13,32570%
- Travel & lodging$4,12522%
- Food & beverage$1,7169%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 37 | $17,024 |
| Bone Support Inc. | 8 | $1,870 |
| Sanara Medtech Inc. | 1 | $43 |
| Amgen | 2 | $38 |
| Smith+Nephew | 1 | $31 |
| Paratek Pharmaceuticals, Inc. | 2 | $30 |
| Johnson & Johnson | 1 | $26 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Nevro Corp. | 1 | $19 |
| Amarin Pharma, Inc. | 1 | $19 |
| Philips North America LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,166 in reported general payments places this provider in the 90th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 52 | $792 |
| Gentamicin Sulfate | 20 | $473 |
| Ketoconazole | 26 | $344 |
| Ammonium Lactate | 12 | $281 |
| Doxycycline Hyclate | 19 | $238 |
| Cephalexin | 24 | $200 |
| Methylprednisolone | 29 | $189 |
| Mupirocin | 22 | $160 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $91 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Shenandoah
- Sarah SykesShenandoah$13K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$452K
- Alan GarrettFort Worth$185K
- Gregory JarygaFt Worth$175K
- Brandon LampeMesquite$154K
- Andrew SchneiderHouston$150K
- Patrick BriggsWebster$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.